Protocol summary

Study aim
The effect of oral melatonin in reduction pain during venipuncture in children referred to Taleghani Children's Hospit
Design
The study will be conducted on children aged 3 to 6 who will be referred to the hospital for whom venipuncture will be performed. The children will be randomly divided into two groups A (melatonin receivers) and B group (placebo receivers). The study is double blind.
Settings and conduct
The study will be conducted in Taleghani Hospital, Gorgan, on children aged 3 to 6 who will undergo vein extraction. The children will be randomly divided into two groups: A (melatonin recipient) and B group (placebo recipient). The study is double blind
Participants/Inclusion and exclusion criteria
inclusion criteria : children with 3-6 y old reffered to Taleghani hospital need to venipuncture for intravenous infusion parental consent to participate in the study exclusion criteria : loss of consciousness acut and lifethreatening state any psycological disorder ( ADHD , autism) receive any sedative or pain releif drug emergency state
Intervention groups
melatonin recipient group
Main outcome variables
Pain score

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20220812055665N1
Registration date: 2022-11-28, 1401/09/07
Registration timing: registered_while_recruiting

Last update: 2022-11-28, 1401/09/07
Update count: 0
Registration date
2022-11-28, 1401/09/07
Registrant information
Name
Zohre Akbari jokar
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 3623 9056
Email address
zohreakbari2351@yahoo.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2022-11-06, 1401/08/15
Expected recruitment end date
2023-03-21, 1402/01/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
The effect of oral melatonin in reduction pain during venipuncture _a double blind clinical trial
Public title
The effect of oral melatonin in reduction pain during venipuncture _a double blind clinical trial
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
children with 3-6 y reffered to Taleghani Hospital Parental consent for the child to participate in the study need to venipuncture for intravenous infusion
Exclusion criteria:
loss of consciousness acute and life threatening state any psychological disorder ( autism , ADHD) any reaction to melatonin use any sedative or pain relief drug emergency state
Age
From 3 years old to 6 years old
Gender
Both
Phase
3
Groups that have been masked
  • Participant
  • Care provider
  • Investigator
Sample size
Target sample size: 202
Randomization (investigator's opinion)
Randomized
Randomization description
Randomization method and tool: In this study, we will use the restricted randomization method of the block randomization type. Blocking is usually used in order to create a balance in the number of samples allocated to each of the studied groups. This feature helps researchers to ensure that the number of samples allocated to each of the study groups is equal in cases where intermediate analyzes are needed during the sampling process. The total size of the blocks is equal and in this trial we will have two groups of 6 blocks including 3 participants in the intervention group and 3 participants in the control group. The randomization tool is also used from random allocation software, which, in addition to simple randomization, is capable of generating random sequences using the block method.
Blinding (investigator's opinion)
Double blinded
Blinding description
Concealment: We will use allocation concealment. By using opaque letter envelopes sealed with a random sequence, in this method, each of the generated random sequences is recorded on a card and the cards are placed inside the letter envelopes in order. In order to maintain a random sequence, the outer surface of the envelopes is numbered in the same order. Finally, the lid of the letter envelopes is glued and placed in a box. At the time of starting the registration of participants, based on the order in which eligible participants entered the study, one of the envelopes will be opened and the assigned group of that participant will be revealed. Double masked blind Both patients and all researchers related to patients are unaware of the patient's perceived exposure. The patient can be identified with a code that is placed in an envelope, and in another place it is clear whether this number is a medicine or a placebo.
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Golestan University of medical science
Street address
Hirkan Blvd
City
Gorgan
Province
Golestan
Postal code
۴۹۳۴۱۷۴۵۱۵
Approval date
2022-10-16, 1401/07/24
Ethics committee reference number
IR.GOUMS.REC.1401.351

Health conditions studied

1

Description of health condition studied
Pain during venipuncture
ICD-10 code
G89.18
ICD-10 code description
Other acute postprocedural pain

Primary outcomes

1

Description
pain score is primary outcome.
Timepoint
30 to 60 min after drug consumption
Method of measurement
FLACC score ( measurement changes of face,legs,activity,cry,consolability)

Secondary outcomes

1

Description
secondary outcome is anxiety
Timepoint
30-60 min after drug consumption
Method of measurement
observation

2

Description
success in venipuncture
Timepoint
30-60 min after drug consumption
Method of measurement
observation

3

Description
child cooperation
Timepoint
30-60 min after drug consumption
Method of measurement
observation

Intervention groups

1

Description
Intervention group: This group includes children to reduce pain and restlessness during venipuncture, melatonin drug will be used for them before venipuncture, and then the success of this method will be evaluated. This group includes 3 to 6 year old children receiving melatonin medication, who receive a single dose of 0.5 mg/kg and a maximum dose of 5 mg 30 to 60 minutes before venipuncture. The melatonin tablet is from jalinous company and has a dose of 5 mg, which is dissolved in 5 cc of water by a trained nurse before use and is given to the child with the mentioned dose. Older children can take the medicine in pill form. After 30 to 60 minutes, venipuncture will be done, and during venipuncture, the child's reactions will be evaluated based on the flacc criteria.
Category
N/A

2

Description
Control group: This group includes children to reduce pain and restlessness during venipuncture, melatonin placebo will be used for them before venipuncture, and then the success of this method will be evaluated. This group includes children aged 3 to 6 years who receive a single dose of placebo with a dose of 0.5 mg/kg and a maximum dose of 5 mg 30 to 60 minutes before venipuncture. The melatonin placebo is from jalinuos company and is completely similar to the 5 mg melatonin tablet. The placebo is dissolved in 5 cc of water by a trained nurse and given to the child with the mentioned dose. Older children can take the medicine in the form of tablets with the correct dosage. After 30 to 60 minutes, venipuncture will be done, and during venipuncture, the child's reactions will be evaluated based on the flacc criteria.
Category
N/A

Recruitment centers

1

Recruitment center
Name of recruitment center
Taleghani hospital
Full name of responsible person
Zohre Akbari Jokar
Street address
Janbazan Blvd
City
Gorgan
Province
Golestan
Postal code
4916668198
Phone
+98 17 3222 7720
Email
zohreakbari2351@yahoo.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Gorgan University of Medical Sciences
Full name of responsible person
Mrs. Professor Narges Begum Mir Behbahani
Street address
Gorgan , janbazan Blvd , taleghani's hospital
City
Gorgan
Province
Golestan
Postal code
۴۹۱۶۶۶۸۱۹۸
Phone
+98 17 3222 7720
Email
n.mirbehbahani@gmail.com
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Gorgan University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Gorgan University of Medical Sciences
Full name of responsible person
Zohre Akbari jokar
Position
Pediatric resident
Latest degree
Specialist
Other areas of specialty/work
Pediatrics
Street address
15 Golara, 8 golshahr, golshahr blvd, gorgan
City
Gorgan
Province
Golestan
Postal code
4916984654
Phone
+98 17 3252 2711
Fax
Email
Zohreakbari2351@yahoo.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Gorgan University of Medical Sciences
Full name of responsible person
Zohre Akbari Jokar
Position
pediatrician doctor
Latest degree
Specialist
Other areas of specialty/work
Pediatrics
Street address
15 Golara, 8 golshahr, golshahr blvd, gorgan
City
Gorgan
Province
Tehran
Postal code
4916984654
Phone
+98 17 3252 0369
Email
zohreakbari2351@yahoo.com

Person responsible for updating data

Contact
Name of organization / entity
Gorgan University of Medical Sciences
Full name of responsible person
Zohre Akbari jokar
Position
Pediatric resident
Latest degree
Specialist
Other areas of specialty/work
Pediatrics
Street address
15 Golara, 8 golshahr, golshahr blvd, gorgan
City
Gorgan
Province
Golestan
Postal code
4916984654
Phone
+98 17 3252 2711
Fax
Email
Zohreakbari2351@yahoo.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
No - There is not a plan to make this available
Justification/reason for indecision/not sharing IPD
preservation of personal information
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Yes - There is a plan to make this available
Informed Consent Form
No - There is not a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
No - There is not a plan to make this available
Data Dictionary
No - There is not a plan to make this available
Title and more details about the data/document
Statistical Analysis Plan Study protocol Clinical trial report
When the data will become available and for how long
2 months after the results are published.
To whom data/document is available
Researchers working in academic and scientific institutions.
Under which criteria data/document could be used
using data for a larger study using data for similar study
From where data/document is obtainable
Dr zohre akbari jokar Zohreakbari2351@yahoo.com 09104323922
What processes are involved for a request to access data/document
The applicant should contact me via e-mail or mobile phone number and state his request and the reason for the need for information. After consulting with the research group and the Guide master, the information will be provided to them.
Comments
Loading...